State-Of-The-Art Facilities and Exceptional Medical Staff
Experience Scientific Excellence and Business Experience in Preclinical Research
Research Reliable Resource for the Biomedical Community
COVID-ARDs – Preclinical Animal Models
ARDS, shock lung, smoke lung, Danang lung, SIRS, sepsis.
YOUR ONE STOP SHOP!
Experience quick turn around on requests and fast lead in times for your studies! Enjoy high level service and superior reporting to support your program with full preclinical and histopathology services.
CBI JOINES GENESIS – FROM Dr. CAROL MESCHTER Read more
Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services
IMIQUIMOD-INDUCED PSORIASIS. Read more
ANIMALS AND COVID-19 RESEARCH AT CBI
OPEN FOR BUSINESS AT CBI
BUSINESS AS USUAL AROUND HERE
FROM THE DESK OF DR. CAROL MESCHTER
CONTINUING OUR SERVICES TO THE HIGHEST LEVELS AT CBI
CORONAVIRUS TREATMENT STUDIES AT CBI
ONCOLYTIC VIRAL VACCINE AT CBI
Intraocular Lens Implantation Studies
Pompe Disease Studies
Skin Closure Published Article 2018
Wound Healing Studies
Burns and Dermatitis Studies
Visit CBI at SOT 2018 – Annual Meeting and Tox Expo
CBI Congratulates Meridigen Biotech Co. on a Successful IND Project